These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3250252)

  • 1. Sequence of changes in KK mouse nephropathy.
    Wehner H
    Adv Exp Med Biol; 1988; 246():147-56. PubMed ID: 3250252
    [No Abstract]   [Full Text] [Related]  

  • 2. Kidney disease in KK mice: structural, biochemical and functional relationships.
    Reddi AS; Wehner H; Khan MY; Camerini-Davalos RA
    Adv Exp Med Biol; 1988; 246():135-45. PubMed ID: 2854953
    [No Abstract]   [Full Text] [Related]  

  • 3. Kidney disease in KK mice: effect of insulin.
    Camerini-Davalos RA; Reddi AS; Wehner H; Velasco CA
    Adv Exp Med Biol; 1988; 246():333-7. PubMed ID: 3074664
    [No Abstract]   [Full Text] [Related]  

  • 4. Renal histologic changes in diabetes mellitus.
    Lane PH; Steffes MW; Mauer SM
    Semin Nephrol; 1990 May; 10(3):254-9. PubMed ID: 2190282
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of candesartan, an angiotensin II type 1 receptor blocker, on diabetic nephropathy in KK/Ta mice.
    Liao J; Kobayashi M; Kanamuru Y; Nakamura S; Makita Y; Funabiki K; Horikoshi S; Tomino Y
    J Nephrol; 2003; 16(6):841-9. PubMed ID: 14736011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney disease in KK mice: effect of glipizide.
    Reddi AS; Velasco CA; Khan MY; Bloodworth JM; Camerini-Davalos RA
    Adv Exp Med Biol; 1988; 246():305-12. PubMed ID: 3250259
    [No Abstract]   [Full Text] [Related]  

  • 7. Diabetic glomerulopathy in man and experimental animal models.
    Steffes MW; Mauer SM
    Int Rev Exp Pathol; 1984; 26():147-75. PubMed ID: 6400512
    [No Abstract]   [Full Text] [Related]  

  • 8. The cyclin kinase inhibitor p21WAF1/CIP1 is required for glomerular hypertrophy in experimental diabetic nephropathy.
    Al-Douahji M; Brugarolas J; Brown PA; Stehman-Breen CO; Alpers CE; Shankland SJ
    Kidney Int; 1999 Nov; 56(5):1691-9. PubMed ID: 10571777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibitory effect of elastase on diabetic nephropathy in experimental diabetic mice].
    Fujii W
    Hokkaido Igaku Zasshi; 2002 Sep; 77(5):429-38. PubMed ID: 12404758
    [No Abstract]   [Full Text] [Related]  

  • 10. Diabetic nephropathy.
    Wardle EN
    Nephron; 1987; 45(3):177-81. PubMed ID: 3553974
    [No Abstract]   [Full Text] [Related]  

  • 11. Kinetic study of glomerular cells of diabetic rats in relation to the development of irreversible glomerular sclerosis.
    Osawa G; Sasaki T; Sato T; Yamada M; Kitano Y
    J Diabet Complications; 1991; 5(2-3):115-7. PubMed ID: 1770014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes.
    Koya D; Haneda M; Nakagawa H; Isshiki K; Sato H; Maeda S; Sugimoto T; Yasuda H; Kashiwagi A; Ways DK; King GL; Kikkawa R
    FASEB J; 2000 Mar; 14(3):439-47. PubMed ID: 10698958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Histological changes in the kidneys in prolonged alloxan prediabetes, latent and manifest diabetes].
    Nasledova ID; Sokoloverova IM; Onegova RF
    Biull Eksp Biol Med; 1975 Oct; 80(10):119-22. PubMed ID: 1227608
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of insulin therapy on established diabetic nephropathy in rats.
    Petersen J; Ross J; Rabkin R
    Diabetes; 1988 Oct; 37(10):1346-50. PubMed ID: 2970981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AJKD Atlas of Renal Pathology: diabetic nephropathy.
    Najafian B; Fogo AB; Lusco MA; Alpers CE
    Am J Kidney Dis; 2015 Nov; 66(5):e37-8. PubMed ID: 26498421
    [No Abstract]   [Full Text] [Related]  

  • 16. Glomerular alterations in experimental diabetes of the rat.
    Wehner H; Petri M
    Pathol Res Pract; 1983 Mar; 176(2-4):145-57. PubMed ID: 6856514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathology of diabetic nephropathy].
    Hara M; Takagawa R; Ishida A
    Nihon Rinsho; 1997 Oct; 55 Suppl():783-8. PubMed ID: 9392197
    [No Abstract]   [Full Text] [Related]  

  • 18. Diabetic nephropathy in KK and KK-Ay mice.
    Okazaki M; Saito Y; Udaka Y; Maruyama M; Murakami H; Ota S; Kikuchi T; Oguchi K
    Exp Anim; 2002 Apr; 51(2):191-6. PubMed ID: 12012732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tubular overexpression of Gremlin in transgenic mice aggravates renal damage in diabetic nephropathy.
    Marchant V; Droguett A; Valderrama G; Burgos ME; Carpio D; Kerr B; Ruiz-Ortega M; Egido J; Mezzano S
    Am J Physiol Renal Physiol; 2015 Sep; 309(6):F559-68. PubMed ID: 26155842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mice deficient in PAPP-A show resistance to the development of diabetic nephropathy.
    Mader JR; Resch ZT; McLean GR; Mikkelsen JH; Oxvig C; Marler RJ; Conover CA
    J Endocrinol; 2013 Oct; 219(1):51-8. PubMed ID: 23881937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.